Rigel Pharmaceuticals RIGL Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's unrecognized tax benefits - income tax penalties and interest accrued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's unrecognized tax benefits - income tax penalties and interest accrued?
- Rigel Pharmaceuticals (RIGL) reported unrecognized tax benefits - income tax penalties and interest accrued of $0 in Q4 2025.
- What does unrecognized tax benefits - income tax penalties and interest accrued mean?
- This metric tracks the accrued interest and penalties associated with the company's unrecognized tax benefits. It represents the additional cost the company would incur if its uncertain tax positions were disallowed by tax authorities. It serves as a proxy for the financial risk associated with the company's tax strategy.